We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$135M
AUM Growth
-$22M
Cap. Flow
-$25.1M
Cap. Flow %
-18.68%
Top 10 Hldgs %
55.15%
Holding
156
New
39
Increased
27
Reduced
28
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 31.89%
2 Healthcare 28.92%
3 Financials 8.63%
4 Consumer Discretionary 6.74%
5 Communication Services 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADAP
126
DELISTED
Adaptimmune Therapeutics
ADAP
-159,351
Closed -$859K
AKRO
127
DELISTED
Akero Therapeutics
AKRO
-27,739
Closed -$716K
ASMB icon
128
Assembly Biosciences
ASMB
$540M
-1,239
Closed -$90K
CDTX
129
DELISTED
Cidara Therapeutics
CDTX
-1,060
Closed -$42K
CYTK icon
130
Cytokinetics
CYTK
$10.6B
-47,520
Closed -$987K
DYN icon
131
Dyne Therapeutics
DYN
$4.99B
-23,760
Closed -$499K
FOLD
132
DELISTED
Amicus Therapeutics
FOLD
-39,774
Closed -$918K
GERN icon
133
Geron
GERN
$1.05B
-428,069
Closed -$681K
IMVT icon
134
Immunovant
IMVT
$8.45B
-17,905
Closed -$827K
LAB icon
135
Standard BioTools
LAB
$309M
-11,000
Closed -$66K
MTRX icon
136
Matrix Service
MTRX
$330M
-10,500
Closed -$116K
RLMD icon
137
Relmada Therapeutics
RLMD
$477M
-22,450
Closed -$720K
RMNI icon
138
Rimini Street
RMNI
$449M
-13,499
Closed -$60K
SRPT icon
139
Sarepta Therapeutics
SRPT
$1.92B
-5,667
Closed -$966K
TEO icon
140
Telecom Argentina
TEO
$5.81B
-10,800
Closed -$71K
TGTX icon
141
TG Therapeutics
TGTX
$7.64B
-27,210
Closed -$1.42M
SEI
142
Solaris Energy Infrastructure
SEI
$3.87B
-12,404
Closed -$101K
CMRX
143
DELISTED
Chimerix, Inc.
CMRX
-20,767
Closed -$100K
SYRS
144
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-1,100
Closed -$119K
CDMO
145
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-10,300
Closed -$119K
DCPH
146
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-11,534
Closed -$658K
CBAY
147
DELISTED
Cymabay Therapeutics
CBAY
-116,519
Closed -$669K
SURF
148
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-10,100
Closed -$93K
GBT
149
DELISTED
Global Blood Therapeutics, Inc.
GBT
-17,389
Closed -$753K
NPTN
150
DELISTED
NEOPHOTONICS CORP
NPTN
-12,700
Closed -$115K

Similar funds

HighVista Strategies's Q1 2021 Portfolio in Review

As of Q1 2021, HighVista Strategies held 156 positions worth $135M, down 14% from $157M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

HighVista Strategies withdrew a net $25.1M in Q1 2021, closing 31 positions and reducing 28 holdings. Its most notable exit was Tiffany & Co., an estimated $6.72M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

Against the trend, HighVista Strategies opened a new position in MSD Acquisition Corp. Unit worth $5.08M.

  • HighVista Strategies's largest Q1 2021 buy was MSD Acquisition Corp. Unit: 500,000 shares worth $5.08M.
  • HighVista Strategies added most to Alibaba in Q1 2021, an estimated $700K increase.
  • HighVista Strategies's biggest Q1 2021 reduction was Dell, cutting an estimated $26.3M.
  • HighVista Strategies fully exited Tiffany & Co. in Q1 2021, selling an estimated $6.72M.
  • HighVista Strategies's ten largest holdings make up 55% of its $135M portfolio in Q1 2021.
  • HighVista Strategies opened 39 new positions and closed 31 in Q1 2021.
  • HighVista Strategies's portfolio value fell 14% quarter-over-quarter to $135M.

Based on HighVista Strategies's 13F filing for Q1 2021, filed 17 May 2021.